Health Care: Drugs

Cardiome Pharma Corporation (CRME: NASDAQ)

$1.94 0.00 | 0.00%
05/24/13 - 03:59 PM ET
Company Income Statement
Dec 2012 Dec 2011 Dec 2010 Dec 2009
Sales 789.00K 1.50M 66.06M 52.21M
Cost of Sales 0.00 0.00 0.00 0.00
Gross Operating Profit 789.00K 1.50M 66.06M 52.21M
Selling, General, and Administrative Expenses 9.61M 11.55M 12.88M 16.25M
Research & Development 6.02M 15.22M 15.34M 29.12M
Operating Income before D & A (EBITDA) -14.84M -25.27M 37.85M 6.85M
Depreciation & Amortization 1.23M 1.10M 1.15M 3.11M
Interest Income 0.00 0.00 0.00 244.48K
Other Income - Net 12.06M 756.00K 803.00K -5.20M
Special Income / Charges 0.00 -95.00K -25.00K 0.00
Total Income Before Interest Expenses (EBIT) -14.05M -25.70M 37.47M -1.22M
Interest Expense 4.27M 2.22M 1.98M 0.00
Pre-Tax Income -18.32M -27.92M 35.50M -1.22M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -18.32M 0.00 0.00 0.00
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -18.32M 0.00 0.00 0.00
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -18.32M -27.92M 35.50M -1.22M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -8.28M 95.00K 25.00K 0.00
Preferred Dividends
Net Income Available To Common -18.32M 0.00 0.00 0.00
Basic EPS from Continuing Ops. -1.50 -2.30 2.90 -0.10
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.50 -2.30 2.90 -0.10
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.50 -2.30 2.90 -0.10
Basic Normalized Net Income/Share -0.68 n.a. n.a. n.a.
EPS fr Continuing Ops. -1.50 -2.30 2.90 -0.10
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.50 -2.30 2.90 -0.10
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.50 -2.30 2.90 -0.10
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)		 -0.68 n.a. n.a. n.a.
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with CRME

View All

Latest CRME Headlines from TheStreet

More Financial News for CRME

Press Releases for CRME

See All Press Releases

Partner Headlines for CRME

brokerage partners
watch thestreet tv
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter